Zobrazeno 1 - 3
of 3
pro vyhledávání: '"hMDMX"'
Autor:
van der Burg Marja JM, Wiercinska Eliza, Verlaan-de Vries Matty, Lodder Kirsten, Teunisse Amina FAS, de Lange Job, Lenos Kristiaan, Szuhai Karoly, Jochemsen Aart G
Publikováno v:
Molecular Cancer, Vol 10, Iss 1, p 111 (2011)
Abstract Background In around 50% of all human cancers the tumor suppressor p53 is mutated. It is generally assumed that in the remaining tumors the wild-type p53 protein is functionally impaired. The two main inhibitors of p53, hMDM2 (MDM2) and hMDM
Externí odkaz:
https://doaj.org/article/980bf98ae4b540b38d9c868bb3e4e699
Autor:
Matty Verlaan-de Vries, Kirsten Lodder, Eliza Wiercinska, Karoly Szuhai, Marja van der Burg, Amina F A S Teunisse, Kristiaan Lenos, Aart G. Jochemsen, Job de Lange
Publikováno v:
Molecular Cancer
Molecular Cancer, 10
Molecular Cancer, Vol 10, Iss 1, p 111 (2011)
Molecular Cancer, 10, 111
Molecular Cancer, 10
Molecular Cancer, Vol 10, Iss 1, p 111 (2011)
Molecular Cancer, 10, 111
Background In around 50% of all human cancers the tumor suppressor p53 is mutated. It is generally assumed that in the remaining tumors the wild-type p53 protein is functionally impaired. The two main inhibitors of p53, hMDM2 (MDM2) and hMDMX (MDMX/M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3fe3c2e77f8de5d19c148faaf1d3d09
http://europepmc.org/articles/PMC3179748
http://europepmc.org/articles/PMC3179748
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.